Beyond Air (XAIR) Stock Price, News & Analysis

-0.01 (-0.72%)
(As of 05/17/2024 ET)
Today's Range
50-Day Range
52-Week Range
327,172 shs
Average Volume
328,016 shs
Market Capitalization
$49.37 million
P/E Ratio
Dividend Yield
Price Target

Beyond Air MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
684.7% Upside
$10.75 Price Target
Short Interest
11.21% of Shares Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
0.75mentions of Beyond Air in the last 14 days
Based on 2 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($1.90) to ($1.45) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.64 out of 5 stars

Medical Sector

258th out of 922 stocks

Surgical & Medical Instruments Industry

35th out of 98 stocks

XAIR stock logo

About Beyond Air Stock (NASDAQ:XAIR)

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

XAIR Stock Price History

XAIR Stock News Headlines

Beyond Air Prices Direct Offering Of $16 Mln Of Shares, Warrants
Will Renewed Nvidia Excitement Lift the Entire Market?
Beyond Air (XAIR) Earnings Dates & Reports
Recap: Beyond Air Q3 Earnings
A Preview Of Beyond Air's Earnings
Beyond Air Independent Director Acquires 102% More Stock
See More Headlines
Receive XAIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
3 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
Book Value
$1.40 per share


Free Float
Market Cap
$49.37 million
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

XAIR Stock Analysis - Frequently Asked Questions

Should I buy or sell Beyond Air stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beyond Air in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" XAIR shares.
View XAIR analyst ratings
or view top-rated stocks.

What is Beyond Air's stock price target for 2024?

3 brokerages have issued 1-year target prices for Beyond Air's stock. Their XAIR share price targets range from $8.00 to $15.00. On average, they expect the company's stock price to reach $10.75 in the next twelve months. This suggests a possible upside of 684.7% from the stock's current price.
View analysts price targets for XAIR
or view top-rated stocks among Wall Street analysts.

How have XAIR shares performed in 2024?

Beyond Air's stock was trading at $1.96 at the start of the year. Since then, XAIR stock has decreased by 30.1% and is now trading at $1.37.
View the best growth stocks for 2024 here

When is Beyond Air's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 27th 2024.
View our XAIR earnings forecast

How were Beyond Air's earnings last quarter?

Beyond Air, Inc. (NASDAQ:XAIR) announced its quarterly earnings results on Monday, February, 12th. The company reported ($0.50) EPS for the quarter, topping analysts' consensus estimates of ($0.61) by $0.11. The firm had revenue of $0.39 million for the quarter, compared to analysts' expectations of $0.49 million. During the same period last year, the company earned ($0.43) EPS.

What other stocks do shareholders of Beyond Air own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Beyond Air investors own include OPKO Health (OPK), NVIDIA (NVDA), Pfizer (PFE), Axsome Therapeutics (AXSM), BioCryst Pharmaceuticals (BCRX), Enphase Energy (ENPH), General Motors (GM), Livongo Health (LVGO), Main Street Capital (MAIN) and Ollie's Bargain Outlet (OLLI).

Who are Beyond Air's major shareholders?

Beyond Air's stock is owned by many different retail and institutional investors. Top institutional investors include Gendell Jeffrey L (4.05%), Vanguard Group Inc. (3.88%), Rosalind Advisors Inc. (2.51%) and Wealth Effects LLC (1.13%). Insiders that own company stock include Amir Avniel, Douglas Beck, Erick Lucera, Michael A Gaul, Robert Carey, Ron Bentsur, Steven A Lisi and Yoori Lee.
View institutional ownership trends

How do I buy shares of Beyond Air?

Shares of XAIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:XAIR) was last updated on 5/17/2024 by Staff

From Our Partners